Strumento inattivo

Azioni SINCLAIR IS PHARMA Euronext Paris

Azioni

Prezzo di chiusura Euronext Paris Altri mercati azionari
- ^EUR	-

Sinclair Pharma : Interim Results 2018	27/09/18
European shares bounce as trade deal hopes lift risk appetite	29/08/18
Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28)	29/08/18
Huadong Medicine : Sinclair Pharma says Chinese firms given more time to make takeover offer	16/08/18
Huadong Medicine : Britain's Sinclair Pharma gets takeover interest from Chinese firms, shares soar	05/07/18

Dirigenti	Titolo	Età	Da
Miguel Pardos CEO	Chief Executive Officer	-	01/06/22
Santiago Calavia PRN	Corporate Officer/Principal	-	-
Julie Moreau PRN	Corporate Officer/Principal	-	-

Amministratori	Titolo	Età	Da
Cheng Wei Liu CHM	Chairman	50	-
Miguel Pardos CEO	Chief Executive Officer	-	01/06/22
Gen Li BRD	Director/Board Member	-	27/04/23

Settore

	Variaz. 1 gen.	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21,98%	43,92 Mrd
OTSUKA HOLDINGS CO., LTD.	+24,56%	23,09 Mrd
SANDOZ GROUP AG	+19,25%	15,35 Mrd
CIPLA LIMITED	+14,03%	13,61 Mrd
ZYDUS LIFESCIENCES LIMITED	+46,40%	12,02 Mrd
ONO PHARMACEUTICAL CO., LTD.	-10,14%	7 Mrd
THE MEDICINES COMPANY	-0,05%	6,79 Mrd
STADA ARZNEIMITTEL	-8,87%	5,73 Mrd
ASPEN PHARMACARE HOLDINGS LIMITED	+13,88%	5,6 Mrd